BioSpace News Archive

Sixth Element Capital LLP announces a £3 million investment in NeoPhore, a spin out from Cambridge, UK based PhoreMost Ltd

Held in Frankfurt the world’s largest pharma event saw attendees from 169 countries - 25% of which are CEO or board level.

These data were shared publicly for the first time yesterday as oral podium presentations at the AHA 2017 Annual Scientific Sessions in Anaheim, CA.

Astellas Oncology today announced that Hernani Oliveira of Porto, Portugal, has been chosen as the Grand Prize Winner of the second annual C3 Prize, a global challenge that acknowledges and supports non-medicine innovations aimed at improving the cancer care experience for patients, caregivers and their loved ones.

The JV will operate out of Zhengzhou in Henan province and through a broad network to deliver its services across China and globally.

This comes on the heels of Alcyone receiving the EU CE Mark last month.

The time and location of the presentations will be announced in due time.

O’Brien joins Relay Therapeutics with significant strategic human resources experience in the life sciences industry.

[15-November-2017] MADRID, November 15, 2017 /PRNewswire/ -- PharmaMar (MCE:PHM) has announced today that the Independent Data Monitoring Committee (IDMC) has notified the Company of its recommendation that the Phase III (ATLANTIS) trial currently under way with Zepsyre(R) (PM1183) in combination with doxorubicin in small-cell lung cancer patients should continue without

A new study has been published regarding Tru-D and its deployment at VCU.